Inventor · disambiguated record
Chantal Fürstner
Also filed as: FUERSTNER CHANTAL · FURSTNER CHANTAL · FÜRSTNER CHANTAL
30 granted patents·11 pending applications·559 citations·filing 1997–2019
97Inventor score
Top patents by PatentIndex Score
41 records- 0194US10300062B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2018·Granted May 28, 2019·11 cites·21 claims
- 0294US6451805B1Substituted pyrazole derivatives for the treatment of cardiocirculatory diseasesBAYER AG·Filed 1997·Granted Sep 17, 2002·88 cites·10 claims
- 0393US9949978B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·42 claims
- 0493US9949977B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·19 claims
- 0593US9481672B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2013·Granted Nov 1, 2016·18 cites·44 claims
- 0692US9988367B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Jun 5, 2018·5 cites·14 claims
- 0792US6462068B1Heterocyclylmethyl-substituted pyrazole derivativesBAYER AG·Filed 2000·Granted Oct 8, 2002·37 cites·13 claims
- 0892US6387940B1Heterocyclylmethyl-substituted pyrazole derivativesBAYER AG·Filed 2000·Granted May 14, 2002·40 cites·15 claims
- 0992US6180656B1Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systemsBAYER AG·Filed 1997·Granted Jan 30, 2001·108 cites·14 claims
- 1091US6410740B1Heterocyclylmethyl-substituted pyrazol derivativesBAYER AG·Filed 2000·Granted Jun 25, 2002·32 cites·4 claims
- 1190US6414009B1Heterocyclylmethyl-substituted pyrazol derivativesBAYER AG·Filed 2000·Granted Jul 2, 2002·29 cites·13 claims
- 1290US6166027AHeterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseasesBAYER AG·Filed 1997·Granted Dec 26, 2000·68 cites·14 claims
- 1389US8334291B2Aliphatically substituted pyrazolopyridines, and the use thereofSCHIROK HARTMUT·Filed 2009·Granted Dec 18, 2012·17 cites·5 claims
- 1488US9687476B2Bisaryl-bonded aryltriazolones and use thereofBAYER IP GMBH·Filed 2015·Granted Jun 27, 2017·8 cites·6 claims
- 1584US10526314B2Hydroxyalkyl-substituted heteroaryltriazole derivatives and uses thereofBAYER AG·Filed 2017·Granted Jan 7, 2020·3 cites·6 claims
- 1684US10472348B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted Nov 12, 2019·3 cites·12 claims
- 1783US8084481B2Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptorsMEIER HEINRICH·Filed 2007·Granted Dec 27, 2011·11 cites·11 claims
- 1883US6589949B13-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseasesBAYER AG·Filed 2000·Granted Jul 8, 2003·23 cites·10 claims
- 1982US8202895B2Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereofBRUEGGEMEIER ULF·Filed 2010·Granted Jun 19, 2012·13 cites·30 claims
- 2079US8796324B2Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereofBRÜGGEMEIER ULF·Filed 2012·Granted Aug 5, 2014·6 cites·8 claims
- 2176US10815205B2Amide-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Oct 27, 2020·2 cites·13 claims
- 2275US9695131B2Substituted uracils as chymase inhibitorsBayer Pharma AG·Filed 2014·Granted Jul 4, 2017·2 cites·4 claims
- 2374US9751843B2Substituted uracils and use thereofBayer Pharma AG·Filed 2014·Granted Sep 5, 2017·2 cites·10 claims
- 2473US9187466B2Bisaryl-bonded aryltriazolones and use thereofFURSTNER CHANTAL·Filed 2011·Granted Nov 17, 2015·4 cites·9 claims
- 2572US9180120B2Substituted N-phenethyltriazoloneacetamides and use thereofFÜRSTNER CHANTAL·Filed 2011·Granted Nov 10, 2015·3 cites·3 claims
- 2669US9926305B2SaltsBayer Pharma AG·Filed 2014·Granted Mar 27, 2018·1 cites·21 claims
- 2765US2020061063A1Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2019·Application pending·0 cites
- 2864US9034855B2Substituted phenylacetate and phenylpropane amides and use thereofFÜRSTNER CHANTAL·Filed 2011·Granted May 19, 2015·1 cites·8 claims
- 2964US2019144423A1Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Application pending·0 cites
- 3058US10703742B2Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4-triazole derivativesBayer Pharma AG·Filed 2017·Granted Jul 7, 2020·0 cites·10 claims
- 3150US8859601B2Substituted benzyl and phenylsulfonyl triazolones, and use thereofBRÜGGEMEIER ULF·Filed 2009·Granted Oct 14, 2014·0 cites·7 claims
- 3250US2010004235A1Heterocyclic Substituted, Anellated Pyrazole Derivative and its usesBAYER HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 3348US2017267648A1Substituted uracils as chymase inhibitorsBayer Pharma AG·Filed 2017·Application pending·0 cites
- 3447US2020230136A1Selective adrenoreceptor alpha2c receptor antagonists alone, or in combination with chymase inhibitors for use in the treatment and/or prophylaxis of peripheral artery diseases (pad)BAYER AG·Filed 2018·Application pending·0 cites
- 3547US2010113507A13-Tetrazolyl Indazoles, 3-Tetrazolyl Pyrazolopyridines, and use ThereofBAYER HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 3646US2013005704A1Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptorsBAYER PHARMA AKTIENGESELLSHAFT·Filed 2011·Application pending·0 cites
- 3746US2016287599A1Substituted 1,2,4-triazine-3,5-diones and the use thereof as chymase inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3839US2019119251A1Amide-substituted aryltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Application pending·0 cites
- 3935US2012208852A1Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereofFUERSTNER CHANTAL·Filed 2010·Application pending·0 cites
- 4029US6344471B12-aminocarbonyl-5(2H)-isoxazolones as ligands of a DFP-binding site treatment of CNS-diseasesBAYER AG·Filed 1999·Granted Feb 5, 2002·0 cites·9 claims
- 4129US2012053218A1Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiencyBRUEGGEMEIER ULF·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chantal Fürstner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →